We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





Identification of COVID Proteins Responsible for Damaging Blood Vessels to Help Develop Targeted Drugs for COVID-19

By HospiMedica International staff writers
Posted on 08 Nov 2021
Print article
Image: Illustration of Coronavirus in blood vessel (Photo courtesy of Tel Aviv University)
Image: Illustration of Coronavirus in blood vessel (Photo courtesy of Tel Aviv University)

For the first time since the outbreak of COVID-19, researchers have been able to identify five of the 29 proteins which make up the SARS-CoV-2 virus that are responsible for damaging blood vessels.

The findings of the study conducted by a team of experts at Tel Aviv University (Tel Aviv, Israel) has raised hopes that the identification of these proteins will help develop targeted drugs for COVID-19 that reduce vascular damage. Two years into the global pandemic, we still do not know which of the proteins in the SARS-CoV-2 virus are the ones responsible for cases of severe vascular damage. The novel coronavirus is a relatively simple virus – it comprises a total of 29 different proteins (compared to the tens of thousands of proteins produced by the human body). For their study, the researchers used the RNA of each of the COVID-19 proteins and examined the reaction that occurred when the various RNA sequences were inserted into human blood vessel cells in the lab; they were thereby able to identify five coronavirus proteins that damage the blood vessels.

“We thoroughly examined the effect of each of the 29 proteins expressed by the virus, and were successful in identifying the five specific proteins that cause the greatest damage to endothelial cells and hence to vascular stability and function,” said Dr. Ben Maoz of TAU’s Department of Biomedical Engineering and Sagol School of Neuroscience. “In addition, we used a computational model developed by Prof. [Roded Sharan of the Blavatnik School of Computer Science] which allowed us to assess and identify which coronavirus proteins have the greatest effect on other tissues, without having seen them ‘in action' in the lab.”

According to Dr. Maoz, the identification of these proteins may have significant consequences in the fight against the virus. “Our research could help find targets for a drug that will be used to stop the virus’s activity, or at least minimize damage to blood vessels.”

Related Links:
Tel Aviv University 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Blood Thawing System
SAHARA-III MAXITHERM 230 V
New
4K Ultra-HD Fluorescence Imaging Camera
SV-M4K40

Print article

Channels

Critical Care

view channel
Image: The AI-powered algorithm offers quick, no-contact screenings for high blood pressure and diabetes (Photo courtesy of 123RF)

AI-Powered Algorithm Offers Quick, Contactless Blood Pressure and Diabetes Screening

A newly developed system that combines high-speed video with an artificial intelligence (AI)-powered algorithm may provide a quick, non-contact method for screening high blood pressure and Type 1 or Type... Read more

Surgical Techniques

view channel
Image: Catheters coated with the new material showed a significant reduction in clotting on the device surface (Photo courtesy of UBC Faculty of Medicine)

Newly Developed Coating Makes Medical Devices Clot-Free

Thrombosis, or the formation of blood clots, presents a significant challenge for devices that come into contact with blood. Unlike natural blood vessels, these devices can activate specific proteins in... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.